ACTG A5221 STRIDE: An International Randomized Trial of Immediate vs Early Antiretroviral Therapy (ART) in HIV 1 Patients Treated for Tuberculosis

Citation:

Havlir, D., et al., 2011. ACTG A5221 STRIDE: An International Randomized Trial of Immediate vs Early Antiretroviral Therapy (ART) in HIV 1 Patients Treated for Tuberculosis. In 18th conference on retroviruses and opportunistic infections. Boston, USA.